Murine lymphocytes are relatively refractory to efficient transfection or retroviral gene transduction. Adenovirus has been used as a vector to transduce a wide variety of cell types. Several advantages of adenoviruses are their ability to transduce non-cycling cells and to transduce the majority of cells in a population. Unfortunately, lymphocytes are not susceptible to infection with conventional adenovirus. Therefore, to express genes efficiently in murine B cells, we tested the ability of genetically modified adenovirus to transduce the ␤-galactosidase gene. We found that adenovirus containing polylysine in the fiber knob was able to efficiently transduce lipopolysaccharide (LPS)-activated splenic B cells and the B lymphoma line M12.4.1; greater than 80% of the cells expressed ␤-galactosidase activity. However, small resting B cells did not express activity unless treated with LPS after infection. This transduction was mediated by inter-
Introduction
Normal lymphocytes and primary tumors of the lymphocyte lineage are historically difficult to transfect efficiently. Development of a system to achieve efficient gene expression in normal cells and cancer cells is an important goal with broad research and therapeutic utility in human and animal models. Previous attempts to transduce B and T lymphocytes using retrovirus, DEAE dextran, or liposomes have had limited success. Recent attempts to express genes in activated murine T cells using retrovirus-based approaches 1 or gene gun technology 2 have resulted in gene expression with an efficiency reported to be between only 10 and 30%. 1, 2 This relatively low efficiency hinders the ability to express genes in normal lymphocyte populations to test their contribution to normal biological responses without further manipulation.
Recent results suggest that the adenovirus may be a suitable vector to express genes in primary lympho-action with charged molecules since heparan-sulfate, and to a lesser degree chondroitan sulfate, inhibited the transduction. In addition, adenovirus containing a FLAG epitope in the fiber protein was used to target the FcR expressed on B cells using an anti-FLAG antibody. In the presence of anti-FLAG, the modified adenovirus was able to efficiently transduce LPS-activated B cells and several B cell lymphoma lines. Interestingly, in the absence of anti-FLAG, there was low level transduction in the LPS-blasts and in M12.4.1 that was not inhibited by soluble adenovirus fiber protein or agents that block RGD-integrin interactions. These results demonstrate that modified adenovirus efficiently transduce B lymphoctyes which will be critical for targeting genes to normal or malignant B cells. Gene Therapy (2001) 8, 938-945.
cytes. [3] [4] [5] [6] [7] Adenovirus infects a host cell by interaction of at least two coat proteins with two cell surface receptors. The fiber protein interacts with the coxsackievirus-adenovirus receptor 3 (CAR). 8, 9 In addition, it has been reported that the fiber protein can interact with the ␣2-domain of human major histocompatibility complex (MHC) class I. 10, 11 After the fiber-mediated attachment of adenovirus to the cell surface, the penton base interacts with ␣v␤3 and ␣v␤5 integrins which in some cell types can enhance/mediate virus internalization through RGD motifs. [12] [13] [14] Previous hindrances to the use of adenovirus as a vector for targeting genes are the limited pattern of expression and low surface levels of CAR. For example, macrophages, T cells, and B cells express little to no CAR. [13] [14] [15] Some success in transducing human B-CLL has been obtained if the cells were activated to elevate the ␣v integrins and transduced at a very high multiplicity of infection. 3 Over the last several years, numerous approaches have been tried to expand the tropism of adenovirus, including the development of mice expressing CAR as a transgene under the control of a T cell-specific promoter 5 and the targeting of adenovirus binding to other receptors. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Adenovirus targeting has been achieved by using bispecific antibodies to redirect virus to alternative cell surface 17, 24 and to generate recombinant adenovirus that contain defined receptor-binding motifs in the fiber protein or penton base. 6, 20 For example, a modified adenovirus containing a polylysine stretch at the N-terminus of the fiber protein (Adz.pK7) has been shown to interact with heparan-containing receptors and increase tropism to endothelial cells, smooth muscle cells, fibroblasts, and macrophages. [20] [21] [22] [23] In addition, this form of adenovirus has recently been shown to transduce human acute myeloid leukemia cells and fresh human myeloma cells. 4 The expression of genes in primary murine B lymphocyte populations for basic mechanistic and pre-clinical analyses is an important goal. Therefore, in this study we have tested the efficacy of two different recombinant adenoviruses to transduce the ␤-galactosidase gene into primary murine B cells and murine B cell lymphoma lines. One virus contains a polylysine heparan-binding motif while the other contains the FLAG epitope. We found that the modified adenovirus can efficiently transduce lipopolysaccharide (LPS)-activated B cells and B lymphoma lines, but not resting B cells. Importantly, these modified viruses transduce the majority of the target population, making them desirable vectors to deliver genes of interest.
Results
In order to achieve efficient transduction of genes into normal and malignant B cells, we tested the ability of several different versions of modified adenovirus to transduce murine B cells (Figure 1 ) with cDNA encoding ␤-galactosidase driven by the CMV promoter. Various
Gene Therapy concentrations of wild-type adenovirus (Adz) or Adz.pK7 containing polylysine in the fiber protein were used to transduce small resting B cells, B cells activated with LPS, and the B lymphoma cell line M12.4.1 (Figure 2) . The epithelial HeLa cell line was used as a positive control for efficient fiber-mediated adenovirus transduction. By analysis of ␤-galactosidase activity in whole cell lysates (Figure 2) , the Adz and the Adz.pK7 were equally efficient at transducing HeLa cells reaching ෂ10 6 RLU at 3000 particles per cell, indicating that the polylysine residues on the Adz.pK7 do not increase or decrease the fiber-CAR interactions. However, neither preparation was able to transduce ␤-galactosidase activity in resting B cells over background seen in the mock-transduced sample. Stimulation of resting B cells with PMA to activate the CMV promoter did not alter the level of ␤-galactosidase activity measured. However, treatment of the resting B cells with LPS for 16 h after infection slightly increased the ␤-galactosidase activity from background levels of 6800 relative light units (RLU) to 26 000 RLU using 3000 particles per cell suggesting that some virus was gaining entry.
Wild-type Adz virus possessed a modest transduction efficiency for LPS blasts (10 4 RLU at 3000 particles per cell) and the M12.4.1 lymphoma (10 5 RLU at 3000 particles per cell). Interestingly, the Adz.pK7 was 10-fold more efficient at transducing the LPS blasts and M12.4.1 than the Adz (10 5 and 10 6 RLU at 3000 particles per cell respectively). The efficiency of transduction of M12.4.1 by Adz.pK7 approached that of HeLa cells. Analysis of ␤-galactosidase activity at the single cell level in normal B cell populations revealed more detail on the adenoviral transduction ( Figure 3 ). In the resting B cell population, there was only a minor subpopulation of cells expressing enzyme activity over background, consistent with the lack of activity in the whole cell lysate assay. Strikingly, in the LPS-activated B cells, the Adz.pK7 transduced more than 85% of the cells while the wild-type virus showed little activity over the mock-transduced control. Greater than 90% of HeLa cells were found to express ␤- galactosidase activity after transduction with either WT Adz or Adz.pK7 (data not shown). These results indicate that the polylysine-modified adenovirus is able to transduce murine B cell blasts and B cell lymphomas efficiently and is a good candidate as a vector to target specific genes to these populations.
To determine whether the enhanced transduction efficiency of Adz.pK7 was due to its ability to interact with negatively charged molecules on the cell surface, blocking studies were performed with heparan sulfate and the less charged molecule chondroitan sulfate ( Figure 4 ). Neither of these proteoglycans had a major effect on the level of ␤-galactosidase activity transduced by Adz.pK7 in HeLa cells. However, heparan sulfate profoundly inhibited transduction of enzyme activity in LPS-B cells (70% decrease at 5 g/ml) and the M12.4.1 lymphoma cells (90% decrease). Chondroitan sulfate was also able to inhibit transduction, however, higher concentrations were necessary and the maximal degree of inhibition was less than that seen using heparan sulfate. These results indicate that the Adz.pK7 enhances gene transduction of murine B cells by interaction with negatively charged molecules on the cell surface such as receptors that contain heparan sulfate.
B lymphocytes possess large numbers of cell surface receptors for the Fc portion of IgG, 25 in particular, they express the Fc␥RII-b1 isoform. While this form of Fc␥R does not participate in receptor-mediated endocytosis via clatherin-coated pits, 26 it has been shown to enhance the uptake of antibody coated Toxoplasma gondii. 27 We reasoned it may be a good candidate for targeting viral entry into polyclonal B cell populations. Therefore, we next tested whether targeting adenovirus to the B cell Fc receptor would enhance transduction efficiency using Adz.F(FLAG). This engineered virus contains the FLAG epitope in the fiber protein while the Adz.PB(FLAG) contains the FLAG epitope in the penton base ( Figure 1 ). We used a monoclonal anti-FLAG antibody of the IgG1 isotype to target the virus to the Fc receptor. These modified virus were incubated with resting and activated primary B cells, several murine B lymphoma lines (CH31, A20, and M12.4.1) and HeLa cells in the presence or absence of the anti-FLAG antibody ( Figure 5 ). Both the Adz.F(FLAG) and the Adz.PB(FLAG) virus were able to transduce efficiently HeLa cells in the presence or absence of anti-FLAG (10 6 RLU at 3000 particles per cell).
Figure 5 Transduction of primary B cells and B lymphoma cell lines by Adz.F(FLAG) or Adz.PB(FLAG). The indicated cells were pre-coated with (᭹) or without (᭺) ␣-FLAG antibody (5 g/ml) for 30 min on ice, and after washing cells, Adz.F(FLAG) or Adz.PB(FLAG) were added and incubated for 1 h at 37°C. The enzyme activity in whole cell lysates was measured 24 h after transduction.
These results indicate that the addition of the FLAG epitope to the fiber or to the penton base neither inhibited nor enhanced the fiber-CAR interaction on HeLa cells. Neither virus was able to transduce resting B cells in the presence or absence of anti-FLAG. However, the ability of these virus to transduce activated B cells and B cell lymphoma lines showed interesting heterogeneity. The Adz.PB(FLAG) virus was not able to transduce these B cell populations in the presence or absence of anti-FLAG even though it was clearly able to transduce HeLa. The Adz. To determine whether the anti-FLAG-mediated enhancement in transduction was due to Fc␥R on the B cell populations, monoclonal anti-Fc␥RII/III (2.4G2) or normal rabbit serum was used to saturate cell surface Fc receptors before addition of anti-FLAG and adenovirus ( Figure 7) . Both agents were able to inhibit the anti-FLAG Gene Therapy enhanced level of ␤-galactosidase activity detected in whole cell lysates down to the levels seen in the absence of anti-FLAG antibody for all three cell types. This is seen most clearly in the A20 cells where the Adz.F(FLAG) virus has a very low efficiency of transduction in the absence of anti-FLAG antibody. These results indicate that targeting to Fc␥R on the surface of B cells can enhance transduction by adenovirus.
Both the M12.4.1 B cell lymphoma line and LPS-activated primary B cells showed some sensitivity to transduction by a WT Ad.z and the Adz.F(FLAG) in the absence of anti-FLAG antibody. These results suggest that these cell types possess a cell surface receptor molecule for adenovirus. While lymphocytes are generally considered to be CAR negative, [13] [14] [15] these populations may express low levels of CAR. In addition, the adenoviral transduction could be mediated by interaction of ␣v integrins with the RGD motifs found in the penton base. Indeed, in addition to expressing Fc␥ receptors, it is reported that normal murine B cells express ␣v integrins 28 which can act as adenovirus coreceptors. 12 To determine the level of expression of ␣v integrin on the surface of resting murine B cells and LPS blasts we used the anti-␣v integrin antibody, anti-CD51 (Figure 8 ). These results show that resting B cells express ␣v integrins and that LPS activation increases expression by four-to five-fold.
To examine the role of fiber-CAR and RGD-␣v integrin interactions in murine B cell transduction, we tested whether soluble fiber protein or RGD peptides could inhibit adenovirus transduction of LPS blasts and M12.4.1 cells as compared with HeLa cells (Figure 9 ). Transduction of HeLa cells by Adz.F(FLAG) was dramatically inhibited by soluble fiber protein, but not by the RGE or RGD peptides indicating that transduction of HeLa cells is largely determined by fiber-CAR interaction. However, neither soluble fiber nor RGD peptide inhibited the transduction of LPS-B cells or M12.4.1 cells even though these cells express ␣v integrins based on positive staining with anti-CD51 antibody (Figure 8 and data not shown). Similar results were obtained when a blocking anti-CD51 antibody was included in the transduction assay (data not shown). These results suggest that neither fiber-CAR nor RGD-␣v integrin interaction contribute substantially to the transduction of the LPS-activated B cells or M12.4.1 cells.
Figure 8 Expression of ␣v integrins on murine B cells. Resting B cells or B cells activated with LPS for 48 h were stained with anti-␣v (anti-CD51)-phycoerythrin in the presence of Fc block. The cells were analyzed by FACS.

Discussion
In this report, we have shown that modified adenovirus efficiently transduces normal murine B cell blasts and several murine B lymphoma lines. One lymphoma line M12.4.1 was transduced by the polylysine-modified virus as efficiently as the adenovirus permissive Hela cell line. The finding that the vast majority of cells are transduced make the modified adenoviral vector a promising approach to studying the importance of signaling molecules in the functions of normal lympocytes. The high level of transduction efficiency (ෂ85%) in the LPS-activated B cell population will allow for signaling studies to be performed on transduced populations of cells without further manipulation such as cell sorting or cloning. Transduction with the Adz.FpK7 virus achieved a higher level of ␤-galactosidase activity compared to the Adz.F(FLAG) virus; due to this higher level of gene delivery and ease of use, the polylysine-modified adenovirus appears to be the better vector for delivery to normal murine B cell blasts.
Resting B cells were not transduced by Adz.FpK7 or Adz.F(FLAG). While the use of PMA to induce expression of ␤-galactosidase from the CMV promoter did not enhance activity, LPS modestly (3.8-fold) enhanced ␤-galactosidase activity. These results indicate that adenovirus can gain entry to resting B cells, but it is not yet clear whether the low level of transduction is due to inefficient adenoviral entry or the lack of expression of critical genes to process the viral DNA and allow transcription from the CMV promoter. Interestingly, a recent study found that resting B cells were much more resistant to adenoviral transduction than T cells. 29 Wan et al 29 found that resting T lymphocytes from CAR transgenic mice were transduced by adenoviral vectors using either the CMV promoter or the UbC promoter. However, resting B cells from the CAR transgenic mice were not transduced by either, even though they expressed CAR on the cell surface. Even after activation with mitogen, only 28% of the CAR-transgenic B cells showed evidence of transduction. Therefore, it is likely that the low level of transduction we observed in resting cells cannot be simply explained by our use of the CMV promoter, but rather reflects the inherent difficulty in transducing B cells with adenovirus. Even with the limitations of the CMV promoter in lymphocytes, the polylysine modification examined here allowed for high level of gene expression in Ͼ85% of the cells. Both the pK7 virus and the FLAG virus transduced B cells with specificity for the targeted receptor. Transduction with Adz.FpK7 was dependent on negatively charged molecules expressed on B cells since heparan sulfate efficiently blocked transduction. In addition, treatment of a number of cell types with heparinase reduced the ability of pK7 to mediate transduction indicating that the polylysine epitope on Adz.FpK7 targets to heparancontaining proteins on the cell surface. 4, 15 Mature, naive B cells lack expression of the heparan sulfate proteoglycan (HSPG) syndecan-1. 29 However, after activation and differentiation B cells express high levels of syndecan-1 (CD138). [30] [31] [32] Elevated expression of HSPG such as syndecan-1 could act as a targets for the pK7 virus in LPSstimulated B cells. 4 Interestingly, targeting adenovirus to the Fc␥II receptor on B cells using monoclonal IgG1 specific for the FLAG epitope resulted in enhanced transduction of the B lymphomas A20 and M12.4.1 and LPS blasts at low multiplicity of infection. B cells express the b1 isoform of Fc␥RII, which contains 47 more amino acids than the b2 macrophage-specific isoform. 25 These additional amino acids have been shown to suppress the clatherin-coated pit-mediated endocytosis of immune complexes containing protein antigen via the Fc receptor. 26 This additional sequence contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) that recruits the SH2-domain containing 5′-inositol phosphatase (SHIP). 33 Recruitment of SHIP to the cytoplasmic region of Fc␥RII cross-linked to a neighboring antigen receptor, results in inhibition of antigen receptor signaling. Therefore, the Fc␥RII-b1 isoGene Therapy form is not considered endocytic, although it is able to patch and cap. 26 Nevertheless, we found that targeting adenovirus to this receptor using the anti-FLAG antibody resulted in enhancement of transduction. While the Fc␥RII-b1 isoform does not endocytose immune complexes containing simple antigens, 26 it has been shown to mediate internalization of heat-killed Toxoplasma gondii coated with antibody. 27 It was proposed that other cell surface molecules might participate in the internalization of this infectious agent. It is possible that the Fc␥RII allows binding of adenovirus to the B cell surface and that some other molecule mediates the internalization. Since the macrophage-specific b2 isoform is more active in its ability to internalize immune complexes, 26 this strategy for targeting adenovirus to FcR may be more efficacious in monocyte/macrophage populations. In addition, while we were not able to transduce resting B cells with this approach, another approach using a bispecific antibody recognizing both anti-IgM and anti-FLAG might prove more efficient.
Surprisingly, we found that the Adz.PB(FLAG) virus was not able to transduce B cells in the presence or absence of anti-FLAG. The inability of the Adz.PB(FLAG) virus to transduce B cells in the presence or absence of anti-FLAG could be due to the location of the FLAG epitope. Its position in the penton base is near the RGD sequences 17 and its insertion deletes several of them. This initially suggested to us that the RGD sequence was important for mediating viral transduction of murine B cells as has been shown for human B cells. 3, 7, 14 However, inhibition studies (shown in Figure 9 ) did not reveal a major role for RGD-integrin interactions in the transduction of LPS-activated B cells. Other possibilities include (1) the fiber knob of the Adz.PB(FLAG) may cause steric hindrance of the anti-FLAG antibody from interacting effectively with both the FLAG epitope and the Fc receptor 17 or (2) the sequence of the penton base near the RGD motifs is important for interactions with unknown cell surface proteins.
The LPS blasts were transduced at low levels by WT adenovirus and the Adz.F(FLAG) in the absence of anti-FLAG antibody by an unknown mechanism. While these cells express ␣v integrins, the low level of transduction was not substantially inhibited by soluble adenovirus fiber or RGD peptide. However, it is now becoming clear that there may be more players in adenovirus transduction than CAR and ␣v integrins. 6 Several studies have suggested that human MHC molecules may also act as receptors for adenovirus in human cells, and it is possible that murine MHC molecules may be able to mediate lowlevel transduction. In addition to ␣v integrins, other integrins have been shown to interact with the RGD motif found in the penton base including ␣5␤1, ␣m␤2, and ␣6␤1.
6 It is also possible that these cells may express a novel receptor for adenovirus that mediates modest transduction levels.
Based on these studies and others, 3,4 the use of modified adenoviral vectors appears a promising approach for targeting genes into murine B cells. Interestingly, we found that different B lymphoma lines show heterogeneity in their sensitivity to transduction with the Adz.FpK7 and the Adz.F(FLAG) Fc-targeted approach. This differential sensitivity could be potentially important in designing and selecting adenoviral vectors to target specific B lymphomas in humans for use in the gene therapy of cancer and will need further exploration.
Materials and methods
Reagents
The anti-Fc␥RII and III antibody, 2.4G2, 34 and anti-␣v integrin 28 CD51 coupled to phycoerythrin were purchased from Pharmingen (San Diego, CA, USA). Anti-FLAG antibody, M2, heparan sulfate, chondroitan sulfate, and LPS were obtained from Sigma Chemical (St Louis, MO, USA). RGD and RGE peptides were purchased from Life Technologies (Gaithersburg, MD, USA). Soluble adenovirus fiber protein was produced as described. 12 
Viruses
The E1-and E3-deleted wild-type adenovirus type 5 (Adz.WT) contains the ␤-galactosidase gene under a cytomegalovirus (CMV) promoter; it binds to host cells through the coxsackievirus-adenovirus receptor (CAR). The modified adenovirus Adz.pK7 was derived as described 15 from the E4− vector, Adz.11A, to incorporate additional lysine residues on the C-termini of the fiber protein that targets the virus to broadly expressed heparan-containing cellular receptors. Adz.F(FLAG) and Adz.PB(FLAG) were modified to express the FLAG epitope on the fiber coat protein 20 or penton base protein, 17 respectively, as previously described. These viruses were purified and titered as described. 15, 17, 20 Cell lines and primary murine B cells The murine B lymphoma cell lines, A20, CH31, and M12.4.1 were maintained in RPMI complete medium (CM: RPMI supplemented with 5% FBS, 100 U/ml penicillin-streptomycin, 2 mm glutamine, and 1 × 10 −7 m 2-mercaptoethanol). HeLa cells (obtained from ATCC, Manassas, VA, USA) were maintained in DMEM-CM without 2-ME and were used as a positive control for transduction. Mouse splenic B cells were purified from C57Bl/6 mice by careful mincing of spleens followed by incubation in anti-Thy 1 serum and complement (Cedarlane Laboratories, Hornby, ON, Canada) to remove T cells. The small, resting B cells were purified by Percoll (Pharmacia Biotech, Uppsala, Sweden) density gradient fractionation. Activated B cells were produced by culturing resting B cells with LPS (50 g/ml) for 48 h in RPMI-CM.
Adenovirus transduction
For adenovirus transduction, 2-10 × 10 6 cells were suspended in a 96-well U-bottom plate in 200 l of serumfree medium. Adenoviral preparations were added to these cells at varying concentrations (physical particles per cell) and incubated for 1 h at 37°C with plate rocking at 15 min intervals. The cells were washed once with PBS, resuspended in fresh CM, and incubated at 37°C for 24 h. Cells were tested for viability and subsequently analyzed for expression of ␤-galactosidase activity (see below). None of the adenoviral preparations demonstrated toxicity to B cells at the concentrations used in these studies.
To neutralize adenovirus binding and transduction, cells were pre-treated with various concentrations of several neutralizing reagents for 30 min at 4°C before adding the virus. To block Fc-mediated uptake of the FLAGtagged virus, antibodies against the FcR (2.4G2) or normal rabbit serum as a source of polyclonal IgG were used. To inhibit uptake due to charge interaction of the pK7 virus, heparan sulfate or chondroitan sulfate were used. A soluble form of the adenoviral fiber coat protein and the peptides RGD and RGE were used to establish the contributions of CAR and integrins in the virus uptake.
␤-Galactosidase assay ␤-Galactosidase activity in whole cell lysates was measured by using a detection kit from TROPIX (Bedford, MA, USA) according to the manufacturer's protocol. Briefly, the cells were washed in the 96-well plate with PBS before addition of lysis solution. The plates were incubated for 10 min at room temperature, followed by the addition of 100 l of reaction solution containing the substrate 1,2-dioxetane. The plates were incubated for 60-90 min. The RLU were measured by a Microlite luminometer (Dynatech Laboratories, Chantilly, VA, USA).
For detection of ␤-galactosidase in single cells, the FluoReporter LacZ Flow Cytometry Kit (Molecular Probes, Eugene, OR, USA) was used according to the suggested protocol. Briefly, single cell suspensions (5-10 × 10 5 in 100 l) were prewarmed in a 37°C water bath for 20 min. A pre-warmed solution of fluorescein di-␤-dgalactopyranoside (FDG) was added to each sample. The cells were then incubated for 1 min in a 37°C water bath. Subsequently, ice-cold staining medium containing 1 g/ml propidium iodide and 300 m choloroquine was added to stop FDG loading. The cells were analyzed for levels of green fluoresence by FACScan (Becton Dickinson, San Jose, CA, USA).
